Stanford University
Showing 101-120 of 829 Results
-
Chethan Sarabu
Clinical Assistant Professor, Pediatrics - General Pediatrics
BioChethan Sarabu, MD trained in landscape architecture, pediatrics, and clinical informatics builds anastomoses across these fields to design healthier environments and systems. He is a clinical assistant professor of Pediatrics at Stanford Medicine, Director of Clinical Informatics at Sharecare. Across these roles, he works on designing and implementing a wide array of innovations ranging from patient portals, EHR transformation, virtual clinical trials, and A.I. driven digital biomarkers, to health information policy initiatives all through a lens of health equity and patient privacy.
He takes care of patients in a community based academic general pediatrics practice at the Gardner Packard Clinic, a Federally Qualified Health Center, where he has also assisted with EHR implementation and transition. He cares deeply on involving children in their own care and strongly focused on protecting the privacy and confidentiality of adolescents in an increasingly digital healthcare system. He helped to form and co-chair the national workgroup, Shift which has been working to promote equitable interoperability.
Drawing on his background in landscape architecture, Chethan implements and researches nature based health solutions in collaboration with the Stanford Natural Capital Project. Finally, further exploring the role of environment and human health, he is shaping the emergent field of climate health informatics. -
Krishna Saraswat
Rickey/Nielsen Professor in the School of Engineering and Professor, by courtesy, of Materials Science and Engineering
Current Research and Scholarly InterestsNew and innovative materials, structures, and process technology of semiconductor devices, interconnects for nanoelectronics and solar cells.
-
Kavita Sarin, MD, PhD
Associate Professor of Dermatology
Current Research and Scholarly InterestsMy research encompasses two main areas: 1) Using next-generation RNA, whole genome, and exome sequencing, we are investigating the genetic alterations involved in skin cancer progression, response to therapy, and other clinical outcomes and 2) We are developing and implementing genome-wide genetic risk prediction assessments for skin cancer into clinical use and studying the impact of this information on patient care.
-
Peter Sarnow
Burt and Marion Avery Professor of Immunology
Current Research and Scholarly InterestsOur laboratory studies virus-host interactions with an emphasis microRNA-mediated gene regulation and on translational control. The mechanism by which a liver-specific microRNA regulates hepatitis C virus genome replication is under intense scrutiny. In addition, the mechanism of internal ribosome entry in certain cellular and viral mRNAs and its biological role in growth and development is being investigated.
-
Clea Sarnquist, DrPH, MPH
Clinical Associate Professor, Pediatrics - Infectious Diseases
Clinical Associate Professor (By courtesy), Epidemiology and Population HealthBioDr. Sarnquist focuses on applied teaching and research on the development, implementation and evaluation of interventions to decrease gender-based violence and prevent HIV infection, especially among adolescents and children. She is particularly interested in rights-based approaches that tackle the complex interplay of factors that lead to poor health for many children and families. All of her work is applied, with direct links health practice and policy, and usually performed in conjunction with non-governmental organization and government partners. She works both globally and in the U.S., with a focus on sub-Saharan Africa. She is also a medical educator, directing the scholarly concentrations program of the pediatric residency at Stanford, and co-directing the global health concentration for residents
-
Frank Sarnquist
Professor of Anesthesia at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsMedical effects of heart bypass surgery; physiological, effects of high altitude; risk management in anesthesia; anesthesia, education.
-
Amir H. Sarrami
Clinical Instructor, Radiology - Pediatric Radiology
Current Research and Scholarly InterestsArtificial intelligence algorithms for PET/MRI in children with Lymphoma
-
John Louis Sarrao
Director of the SLAC National Accelerator Laboratory, Professor of Photon Science and Senior Fellow at the Precourt Institute for Energy
BioJohn Sarrao became SLAC National Accelerator Laboratory’s sixth director in October 2023. The lab’s ~2,000 staff advance the frontiers of science by exploring how the universe works at the biggest, smallest, and fastest scales and invent powerful tools used by scientists around the globe. SLAC’s research helps solve real-world problems and advances the interests of the nation. SLAC is operated by Stanford University for the U.S. Department of Energy’s Office of Science. It is home to three Office of Science national user facilities: the Linac Coherent Light Source (LCLS), the world’s most powerful X-ray laser; the Stanford Synchrotron Radiation Lightsource (SSRL); and the Facility for Advanced Accelerator Experimental Tests, (FACET-II). SLAC hosts thousands of users each year and manages an annual budget of ~$700M. In addition to his role as lab director, John is a professor of photon science at Stanford University, a senior fellow at Stanford’s Precourt Institute, and dean of SLAC faculty.
John came to SLAC from Los Alamos National Laboratory (LANL) in New Mexico, where he served as the deputy director for science, technology, and engineering. In that role, he led multiple directorates, including chemistry, earth and life sciences, global security, physical sciences, and simulation and computation. He also stewarded technology transitions and served as LANL’s chief research officer in support of its national security mission. Before becoming deputy director, he served as associate director for theory, simulation, and computation and division leader for materials physics and applications at LANL.
John’s scientific research focus is superconductivity in materials. He studies the synthesis and characterization of correlated electron systems, especially actinide materials. He won the 2013 Department of Energy’s E.O. Lawrence Award and is a fellow of the American Association for the Advancement of Science, the American Physical Society, and LANL. John received his PhD and master’s degree in physics from the University of California, Los Angeles, and a bachelor’s degree in physics from Stanford University. -
Anuja Anand Sathe
Instructor, Medicine - Oncology
Current Research and Scholarly InterestsI am interested in understanding the determinants of therapeutic resistance in cancer. I investigate the composition of the tumor microenvironment and adaptive responses to therapy using single-cell and spatial approaches.
-
Ansuman Satpathy
Associate Professor of Pathology
Current Research and Scholarly InterestsOur lab works at the interface of immunology, cancer biology, and genomics to study cellular and molecular mechanisms of the immune response to cancer. In particular, we are leveraging high-throughput genomic technologies to understand the dynamics of the tumor-specific T cell response to cancer antigens and immunotherapies (checkpoint blockade, CAR-T cells, and others). We are also interested in understanding the impact of immuno-editing on the heterogeneity and clonal evolution of cancer.
-
Elizabeth Sattely
Associate Professor of Chemical Engineering
BioPlants have an extraordinary capacity to harvest atmospheric CO2 and sunlight for the production of energy-rich biopolymers, clinically used drugs, and other biologically active small molecules. The metabolic pathways that produce these compounds are key to developing sustainable biofuel feedstocks, protecting crops from pathogens, and discovering new natural-product based therapeutics for human disease. These applications motivate us to find new ways to elucidate and engineer plant metabolism. We use a multidisciplinary approach combining chemistry, enzymology, genetics, and metabolomics to tackle problems that include new methods for delignification of lignocellulosic biomass and the engineering of plant antibiotic biosynthesis.
